Recall: D-0474-2026

Class II - Potentially Harmful

Class IIClassification

2026-03-19Initiated

OngoingStatus

Teva Pharmaceuticals USA, IncFirm

Product

Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch

Reason

CGMP Deviations: use of an unapproved raw material

Distribution

Within U.S

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.